Profile http://med.stanford.edu/profiles/Quynh-Thu_Le/ Email this page Printer friendly version

Key Documents

Quynh-Thu Le

Professor - Med Center Line, Radiation Oncology - Radiation Therapy
Professor - Med Center Line (By courtesy), Otolaryngology (Head and Neck Surgery)
Member, Bio-X
Member, Cancer Center

Contact Information

Clinical Offices

Radiation Therapy 875 Blake Wilbur Dr Clinic D Stanford, CA 94305-5847
Telephone Work (650) 723-6171 Fax (650) 725-8231
Academic Offices

Personal Information

Administrative Contact
Trevor Elizabeth Krakow Research Assistance Email tkrakow@stanford.edu Tel Work 725-4777

Not for medical emergencies or patient use

Clinical Focus

Cancer > Head and Neck Cancer
Cancer > Radiation Oncology
Head and Neck Cancers
Head and Neck Cancers - Radiation Oncology
Larynx Cancer
Larynx Cancer - Radiation Oncology
Lung Cancer - Radiation Oncology
Oral Cavity Cancer
Oral Cavity Cancer - Radiation Oncology
Radiation Oncology
Salivary Gland Tumors
Salivary Gland Tumors - Radiation Oncology
Sarcomas - Soft Tissue
Sarcomas - Soft Tissue - Radiation Oncology
Skull Base Tumors
Skull Base Tumors - Radiation Oncology

Administrative Appointments

Editorial Board, Journal of Clinical Oncology , (2005– 2009 )
IMRT Practicum Course Co-Director, American Society of Therapeutic Oncology and Radiology , (2004– 2009 )
Educational Committee Vice Chair, American Society of Therapeutic Radiology and Oncology , (2005– present )
Director of Clinial research, Department of radiation oncology, stanford university , (2005– present )
Editorial Board, Int J Radiation Oncology Biology Physics , (2003– present )

Professional Education

Board Certification: Radiation Oncology, American Board of Radiology (1998)
UCSF Medical Center (1997) CA
Highland General Hospital (1994) CA
UCSF School of Medicine (1993) CA
MD, UCSF Medicine (1993)

Postdoctoral Advisees

Alice Banh, Karen Pat-Ming Chu, Peiwen Kuo

Graduate & Fellowship Program Affiliations

Radiation Oncology

Research Interests

My laboratory research interest focusses on the identification of serum markers for tumor hypoxia and for prognosis in patients with head and neck or lung cancers. I am also conducting a number of clinical trials specifically in patients with these tumors. For head and neck cancer, I am conducting a trial using iressa, chemotherapy and re-irradiation in patients with unresectable recurrent tumors, a trial using Evoxac to improve radiation-induced xerostomia in previously treated patients, and 2 trials on serum markers for hypoxia and treatment outcomes. For lung cancer patients, I am conducting a phase II trial with Tirapazamine and conventional treatment in patients with limited stage small cell lung cancers through the Southwest Oncology Group and a trial on using stereotactic radiosurgical ablation for small unresectable or metastatic lung tumors.

Clinical Trials

Publications

Integrating biologically targeted therapy in head and neck squamous cell carcinomas. Le QT, Raben D. Semin Radiat Oncol. 2009; 19 (1): 53-62
Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche. Erler JT, Bennewith KL, Cox TR, Lang G, Bird D, Koong A, Le QT, Giaccia AJ. Cancer Cell. 2009; 15 (1): 35-44
X box-binding protein 1 regulates angiogenesis in human pancreatic adenocarcinomas. Romero-Ramirez L, Cao H, Regalado MP, Kambham N, Siemann D, Kim JJ, Le QT, Koong AC. Transl Oncol. 2009; 2 (1): 31-8
Metabolic tumor volume predicts for recurrence and death in head-and-neck cancer. La TH, Filion EJ, Turnbull BB, Chu JN, Lee P, Nguyen K, Maxim P, Quon A, Graves EE, Loo BW, Le QT. Int J Radiat Oncol Biol Phys. 2009; 74 (5): 1335-41
Comparison of treatment results between adult and juvenile nasopharyngeal carcinoma. Downing NL, Wolden S, Wong P, Petrik DW, Hara W, Le QT. Int J Radiat Oncol Biol Phys. 2009; 75 (4): 1064-70
Hypoxia-inducible mir-210 regulates normoxic gene expression involved in tumor initiation. Huang X, Ding L, Bennewith KL, Tong RT, Welford SM, Ang KK, Story M, Le QT, Giaccia AJ. Mol Cell. 2009; 35 (6): 856-67
PET of EGFR antibody distribution in head and neck squamous cell carcinoma models. Niu G, Li Z, Xie J, Le QT, Chen X. J Nucl Med. 2009; 50 (7): 1116-23
Intensity-Modulated Radiotherapy in the Treatment of Oropharyngeal Cancer: Clinical Outcomes and Patterns of Failure. Daly ME, Le QT, Maxim PG, Loo BW, Kaplan MJ, Fischbein NJ, Pinto H, Chang DT. Int J Radiat Oncol Biol Phys. 2009;
Mucositis-related morbidity and resource utilization in head and neck cancer patients receiving radiation therapy with or without chemotherapy. Murphy BA, Beaumont JL, Isitt J, Garden AS, Gwede CK, Trotti AM, Meredith RF, Epstein JB, Le QT, Brizel DM, Bellm LA, Wells N, Cella D. J Pain Symptom Manage. 2009; 38 (4): 522-32
Validation of lysyl oxidase as a prognostic marker for metastasis and survival in head and neck squamous cell carcinoma: Radiation Therapy Oncology Group trial 90-03. Le QT, Harris J, Magliocco AM, Kong CS, Diaz R, Shin B, Cao H, Trotti A, Erler JT, Chung CH, Dicker A, Pajak TF, Giaccia AJ, Ang KK. J Clin Oncol. 2009; 27 (26): 4281-6
The relationship between human papillomavirus status and other molecular prognostic markers in head and neck squamous cell carcinomas. Kong CS, Narasimhan B, Cao H, Kwok S, Erickson JP, Koong A, Pourmand N, Le QT. Int J Radiat Oncol Biol Phys. 2009; 74 (2): 553-61
Molecular imaging of hypoxia-inducible factor 1 alpha and von Hippel-Lindau interaction in mice. Choi CY, Chan DA, Paulmurugan R, Sutphin PD, Le QT, Koong AC, Zundel W, Gambhir SS, Giaccia AJ. Mol Imaging. 2008 May-Jun; 7 (3): 139-46
Retrospective IMRT dose reconstruction based on cone-beam CT and MLC log-file. Lee L, Le QT, Xing L. Int J Radiat Oncol Biol Phys. 2008; 70 (2): 634-44
In vivo 1H magnetic resonance spectroscopy of lactate in patients with stage IV head and neck squamous cell carcinoma. Le QT, Koong A, Lieskovsky YY, Narasimhan B, Graves E, Pinto H, Brown JM, Spielman D. Int J Radiat Oncol Biol Phys. 2008; 71 (4): 1151-7
Clinical biomarkers for hypoxia targeting. Le QT, Courter D. Cancer Metastasis Rev. 2008; 27 (3): 351-62
Lower osteopontin plasma levels are associated with superior outcomes in advanced non-small-cell lung cancer patients receiving platinum-based chemotherapy: SWOG Study S0003. Mack PC, Redman MW, Chansky K, Williamson SK, Farneth NC, Lara PN, Franklin WA, Le QT, Crowley JJ, Gandara DR. J Clin Oncol. 2008; 26 (29): 4771-6
Excellent local control with stereotactic radiotherapy boost after external beam radiotherapy in patients with nasopharyngeal carcinoma. Hara W, Loo BW, Goffinet DR, Chang SD, Adler JR, Pinto HA, Fee WE, Kaplan MJ, Fischbein NJ, Le QT. Int J Radiat Oncol Biol Phys. 2008; 71 (2): 393-400
Linac-based on-board imaging feasibility and the dosimetric consequences of head roll in head-and-neck IMRT plans. Kim GY, Pawlicki T, Le QT, Luxton G. Med Dosim. 2008; 33 (1): 93-9
Evaluation of patterns of failure and subjective salivary function in patients treated with intensity modulated radiotherapy for head and neck squamous cell carcinoma. Daly ME, Lieskovsky Y, Pawlicki T, Yau J, Pinto H, Kaplan M, Fee WE, Koong A, Goffinet DR, Xing L, Le QT. Head Neck. 2007; 29 (3): 211-20
Clinical role of 18F-FDG PET/CT in the management of squamous cell carcinoma of the head and neck and thyroid carcinoma. Quon A, Fischbein NJ, McDougall IR, Le QT, Loo BW, Pinto H, Kaplan MJ. J Nucl Med. 2007; 48 Suppl 1 58S-67S
Expression and prognostic significance of a panel of tissue hypoxia markers in head-and-neck squamous cell carcinomas. Le QT, Kong C, Lavori PW, O'byrne K, Erler JT, Huang X, Chen Y, Cao H, Tibshirani R, Denko N, Giaccia AJ, Koong AC. Int J Radiat Oncol Biol Phys. 2007; 69 (1): 167-75
Nasopharyngeal and oropharyngeal carcinomas: target delineation, therapy delivery and stereotactic boost procedures with intensity-modulated/ image-guided radiation therapy. Le QT, Front Radiat Ther Oncol. 2007; 40 208-31
Quantification of motion of different thoracic locations using four-dimensional computed tomography: implications for radiotherapy planning. Maxim PG, Loo BW, Shirazi H, Thorndyke B, Luxton G, Le QT. Int J Radiat Oncol Biol Phys. 2007; 69 (5): 1395-401
Identifying and targeting hypoxia in head and neck cancer: a brief overview of current approaches. Le QT, Int J Radiat Oncol Biol Phys. 2007; 69 (2 Suppl): S56-8
Metabolic tumor burden predicts for disease progression and death in lung cancer. Lee P, Weerasuriya DK, Lavori PW, Quon A, Hara W, Maxim PG, Le QT, Wakelee HA, Donington JS, Graves EE, Loo BW. Int J Radiat Oncol Biol Phys. 2007; 69 (2): 328-33
Comment on: osteopontin as toxic marker. Le QT, Cao H, Koong A, Giaccia A. Radiother Oncol. 2006; 78 (2): 230; author reply 230-1
Advanced-staged tonsillar squamous carcinoma: organ preservation versus surgical management of the primary site. Shirazi HA, Sivanandan R, Goode R, Fee WE, Kaplan MJ, Pinto HA, Goffinet DR, Le QT. Head Neck. 2006; 28 (7): 587-94
An evaluation of tumor oxygenation and gene expression in patients with early stage non-small cell lung cancers. Le QT, Chen E, Salim A, Cao H, Kong CS, Whyte R, Donington J, Cannon W, Wakelee H, Tibshirani R, Mitchell JD, Richardson D, O'Byrne KJ, Koong AC, Giaccia AJ. Clin Cancer Res. 2006; 12 (5): 1507-14
Mature results from a randomized Phase II trial of cisplatin plus 5-fluorouracil and radiotherapy with or without tirapazamine in patients with resectable Stage IV head and neck squamous cell carcinomas. Le QT, Taira A, Budenz S, Jo Dorie M, Goffinet DR, Fee WE, Goode R, Bloch D, Koong A, Martin Brown J, Pinto HA. Cancer. 2006; 106 (9): 1940-9
Lysyl oxidase is essential for hypoxia-induced metastasis. Erler JT, Bennewith KL, Nicolau M, Dornhöfer N, Kong C, Le QT, Chi JT, Jeffrey SS, Giaccia AJ. Nature. 2006; 440 (7088): 1222-6
Results of a phase I dose-escalation study using single-fraction stereotactic radiotherapy for lung tumors. Le QT, Loo BW, Ho A, Cotrutz C, Koong AC, Wakelee H, Kee ST, Constantinescu D, Whyte RI, Donington J. J Thorac Oncol. 2006; 1 (8): 802-9
Lung cancer in women: exploring sex differences in susceptibility, biology, and therapeutic response. Donington JS, Le QT, Wakelee HA. Clin Lung Cancer. 2006; 8 (1): 22-9
Indirect MR lymphangiography of the head and neck using conventional gadolinium contrast: a pilot study in humans. Loo BW, Draney MT, Sivanandan R, Ruehm SG, Pawlicki T, Xing L, Herfkens RJ, Le QT. Int J Radiat Oncol Biol Phys. 2006; 66 (2): 462-8
A multidisciplinary approach to management in a patient with bilateral superior sulcus non-small-cell lung carcinoma. Roy MS, Le QT, Donington JS, Wakelee HA. Clin Lung Cancer. 2006; 8 (2): 146-8
Plasma osteopontin is an independent prognostic marker for head and neck cancers. Petrik D, Lavori PW, Cao H, Zhu Y, Wong P, Christofferson E, Kaplan MJ, Pinto HA, Sutphin P, Koong AC, Giaccia AJ, Le QT. J Clin Oncol. 2006; 24 (33): 5291-7
Connective tissue growth factor-specific monoclonal antibody therapy inhibits pancreatic tumor growth and metastasis. Dornhöfer N, Spong S, Bennewith K, Salim A, Klaus S, Kambham N, Wong C, Kaper F, Sutphin P, Nacamuli R, Nacalumi R, Höckel M, Le Q, Longaker M, Yang G, Koong A, Giaccia A. Cancer Res. 2006; 66 (11): 5816-27
Nonsurgical therapy for stages I and II non-small cell lung cancer. Le QT, Petrik DW. Hematol Oncol Clin North Am. 2005; 19 (2): 237-61, v-vi
Positron-emission tomography for surveillance of head and neck cancer. Ryan WR, Fee WE, Le QT, Pinto HA. Laryngoscope. 2005; 115 (4): 645-50
A noninvasive approach for assessing tumor hypoxia in xenografts: developing a urinary marker for hypoxia. Nelson DW, Cao H, Zhu Y, Sunar-Reeder B, Choi CY, Faix JD, Brown JM, Koong AC, Giaccia AJ, Le QT. Cancer Res. 2005; 65 (14): 6151-8
Galectin-1: a link between tumor hypoxia and tumor immune privilege. Le QT, Shi G, Cao H, Nelson DW, Wang Y, Chen EY, Zhao S, Kong C, Richardson D, O'Byrne KJ, Giaccia AJ, Koong AC. J Clin Oncol. 2005; 23 (35): 8932-41
A comparison study of different PCR assays in measuring circulating plasma epstein-barr virus DNA levels in patients with nasopharyngeal carcinoma. Le QT, Jones CD, Yau TK, Shirazi HA, Wong PH, Thomas EN, Patterson BK, Lee AW, Zehnder JL. Clin Cancer Res. 2005; 11 (16): 5700-7
Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancer. Koong AC, Christofferson E, Le QT, Goodman KA, Ho A, Kuo T, Ford JM, Fisher GA, Greco R, Norton J, Yang GP. Int J Radiat Oncol Biol Phys. 2005; 63 (2): 320-3
Identification of mitogen-activated protein kinase signaling pathways that confer resistance to endoplasmic reticulum stress in Saccharomyces cerevisiae. Chen Y, Feldman DE, Deng C, Brown JA, De Giacomo AF, Gaw AF, Shi G, Le QT, Brown JM, Koong AC. Mol Cancer Res. 2005; 3 (12): 669-77
Hypoxia upregulates osteopontin expression in NIH-3T3 cells via a Ras-activated enhancer. Zhu Y, Denhardt DT, Cao H, Sutphin PD, Koong AC, Giaccia AJ, Le QT. Oncogene. 2005; 24 (43): 6555-63
Hypoxic gene expression and metastasis. Le QT, Denko NC, Giaccia AJ. Cancer Metastasis Rev. 2004 Aug-Dec; 23 (3-4): 293-310
Phase II double-blind randomized study comparing oral aloe vera versus placebo to prevent radiation-related mucositis in patients with head-and-neck neoplasms. Su CK, Mehta V, Ravikumar L, Shah R, Pinto H, Halpern J, Koong A, Goffinet D, Le QT. Int J Radiat Oncol Biol Phys. 2004; 60 (1): 171-7
Phase I study of tirapazamine plus cisplatin/etoposide and concurrent thoracic radiotherapy in limited-stage small cell lung cancer (S0004): a Southwest Oncology Group study. Le QT, McCoy J, Williamson S, Ryu J, Gaspar LE, Edelman MJ, Dakhil SR, Sides SD, Crowley JJ, Gandara DR. Clin Cancer Res. 2004; 10 (16): 5418-24
The use of plasma surface-enhanced laser desorption/ionization time-of-flight mass spectrometry proteomic patterns for detection of head and neck squamous cell cancers. Soltys SG, Le QT, Shi G, Tibshirani R, Giaccia AJ, Koong AC. Clin Cancer Res. 2004; 10 (14): 4806-12
Sample classification from protein mass spectrometry, by 'peak probability contrasts'. Tibshirani R, Hastie T, Narasimhan B, Soltys S, Shi G, Koong A, Le QT. Bioinformatics. 2004; 20 (17): 3034-44
XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Romero-Ramirez L, Cao H, Nelson D, Hammond E, Lee AH, Yoshida H, Mori K, Glimcher LH, Denko NC, Giaccia AJ, Le QT, Koong AC. Cancer Res. 2004; 64 (17): 5943-7
Extranodal nonorbital indolent lymphomas of the head and neck: relationship between tumor control and radiotherapy. MacDermed D, Thurber L, George TI, Hoppe RT, Le QT. Int J Radiat Oncol Biol Phys. 2004; 59 (3): 788-95
Lens dose in MLC-based IMRT treatments of the head and neck. Pawlicki T, Luxton G, Le QT, Findley D, Ma CM. Int J Radiat Oncol Biol Phys. 2004; 59 (1): 293-9
Phase I study of stereotactic radiosurgery in patients with locally advanced pancreatic cancer. Koong AC, Le QT, Ho A, Fong B, Fisher G, Cho C, Ford J, Poen J, Gibbs IC, Mehta VK, Kee S, Trueblood W, Yang G, Bastidas JA. Int J Radiat Oncol Biol Phys. 2004; 58 (4): 1017-21
Long-term results of 100 consecutive comprehensive neck dissections: implications for selective neck dissections. Sivanandan R, Kaplan MJ, Lee KJ, Lebl D, Pinto H, Le QT, Goffinet DR, Fee WE. Arch Otolaryngol Head Neck Surg. 2004; 130 (12): 1369-73
Identification of hypoxia-regulated proteins in head and neck cancer by proteomic and tissue array profiling. Chen Y, Shi G, Xia W, Kong C, Zhao S, Gaw AF, Chen EY, Yang GP, Giaccia AJ, Le QT, Koong AC. Cancer Res. 2004; 64 (20): 7302-10
Therapeutic exploitation of the physiological and molecular genetic alterations in head and neck cancer. Le QT, Giaccia AJ. Clin Cancer Res. 2003; 9 (12): 4287-95
Long-term outcomes after external beam irradiation and brachytherapy boost for base-of-tongue cancers. Gibbs IC, Le QT, Shah RD, Terris DJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 2003; 57 (2): 489-94
Improved local control with stereotactic radiosurgical boost in patients with nasopharyngeal carcinoma. Le QT, Tate D, Koong A, Gibbs IC, Chang SD, Adler JR, Pinto HA, Terris DJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 2003; 56 (4): 1046-54
Comparison of the comet assay and the oxygen microelectrode for measuring tumor oxygenation in head-and-neck cancer patients. Le QT, Kovacs MS, Dorie MJ, Koong A, Terris DJ, Pinto HA, Goffinet DR, Nowels K, Bloch D, Brown JM. Int J Radiat Oncol Biol Phys. 2003; 56 (2): 375-83
HIF-alpha, a gender independent transcription factor. Le QT, Giaccia AJ. Clin Cancer Res. 2003; 9 (7): 2391-3
Patterns of patient movement during frameless image-guided radiosurgery. Murphy MJ, Chang SD, Gibbs IC, Le QT, Hai J, Kim D, Martin DP, Adler JR. Int J Radiat Oncol Biol Phys. 2003; 55 (5): 1400-8
Identification of osteopontin as a prognostic plasma marker for head and neck squamous cell carcinomas. Le QT, Sutphin PD, Raychaudhuri S, Yu SC, Terris DJ, Lin HS, Lum B, Pinto HA, Koong AC, Giaccia AJ. Clin Cancer Res. 2003; 9 (1): 59-67
Radiation therapy for intracranial germ cell tumors. Haas-Kogan DA, Missett BT, Wara WM, Donaldson SS, Lamborn KR, Prados MD, Fisher PG, Huhn SL, Fisch BM, Berger MS, Le QT. Int J Radiat Oncol Biol Phys. 2003; 56 (2): 511-8
Stereotactic radiosurgery for lung tumors: preliminary report of a phase I trial. Whyte RI, Crownover R, Murphy MJ, Martin DP, Rice TW, DeCamp MM, Rodebaugh R, Weinhous MS, Le QT. Ann Thorac Surg. 2003; 75 (4): 1097-101
Estimating DNA repair by sequential evaluation of head and neck tumor radiation sensitivity using the comet assay. Terris DJ, Ho EY, Ibrahim HZ, Dorie MJ, Kovacs MS, Le QT, Koong AC, Pinto HA, Brown JM. Arch Otolaryngol Head Neck Surg. 2002; 128 (6): 698-702
The effectiveness of breath-holding to stabilize lung and pancreas tumors during radiosurgery. Murphy MJ, Martin D, Whyte R, Hai J, Ozhasoglu C, Le QT. Int J Radiat Oncol Biol Phys. 2002; 53 (2): 475-82
Tirapazamine: prototype for a novel class of therapeutic agents targeting tumor hypoxia. Gandara DR, Lara PN, Goldberg Z, Le QT, Mack PC, Lau DH, Gumerlock PH. Semin Oncol. 2002; 29 (1 Suppl 4): 102-9
Tumor hypoxia is important in radiotherapy, but how should we measure it? Brown JM, Le QT. Int J Radiat Oncol Biol Phys. 2002; 54 (5): 1299-301
Primary radiotherapy for localized orbital MALT lymphoma. Le QT, Eulau SM, George TI, Hildebrand R, Warnke RA, Donaldson SS, Hoppe RT. Int J Radiat Oncol Biol Phys. 2002; 52 (3): 657-63
Daily low-dose carboplatin as a radiation sensitizer for newly diagnosed malignant glioma. Peterson K, Harsh G, Fisher PG, Adler J, Le Q. J Neurooncol. 2001; 53 (1): 27-32
Image-guided hypo-fractionated stereotactic radiosurgery to spinal lesions. Ryu SI, Chang SD, Kim DH, Murphy MJ, Le QT, Martin DP, Adler JR. Neurosurgery. 2001; 49 (4): 838-46
Role of beam orientation optimization in intensity-modulated radiation therapy. Pugachev A, Li JG, Boyer AL, Hancock SL, Le QT, Donaldson SS, Xing L. Int J Radiat Oncol Biol Phys. 2001; 50 (2): 551-60
Treatment results and prognostic factors of advanced T3--4 laryngeal carcinoma: the University of California, San Francisco (UCSF) and Stanford University Hospital (SUH) experience. Nguyen-Tan PF, Le QT, Quivey JM, Singer M, Terris DJ, Goffinet DR, Fu KK. Int J Radiat Oncol Biol Phys. 2001; 50 (5): 1172-80
Image-guided radiosurgery in the treatment of spinal metastases. Murphy MJ, Chang S, Gibbs I, Le QT, Martin D, Kim D. Neurosurg Focus. 2001; 11 (6): e6
Pancreatic tumors show high levels of hypoxia. Koong AC, Mehta VK, Le QT, Fisher GA, Terris DJ, Brown JM, Bastidas AJ, Vierra M. Int J Radiat Oncol Biol Phys. 2000; 48 (4): 919-22
Head and neck cancer in cardiothoracic transplant recipients. Pollard JD, Hanasono MM, Mikulec AA, Le QT, Terris DJ. Laryngoscope. 2000; 110 (8): 1257-61
Image-guided radiosurgery for the spine and pancreas. Murphy MJ, Adler JR, Bodduluri M, Dooley J, Forster K, Hai J, Le Q, Luxton G, Martin D, Poen J. Comput Aided Surg. 2000; 5 (4): 278-88
Lymph node metastasis in maxillary sinus carcinoma. Le QT, Fu KK, Kaplan MJ, Terris DJ, Fee WE, Goffinet DR. Int J Radiat Oncol Biol Phys. 2000; 46 (3): 541-9
Treatment results of carcinoma in situ of the glottis: an analysis of 82 cases. Le QT, Takamiya R, Shu HK, Smitt M, Singer M, Terris DJ, Fee WE, Goffinet DR, Fu KK. Arch Otolaryngol Head Neck Surg. 2000; 126 (11): 1305-12
Candidate genes for the hypoxic tumor phenotype. Koong AC, Denko NC, Hudson KM, Schindler C, Swiersz L, Koch C, Evans S, Ibrahim H, Le QT, Terris DJ, Giaccia AJ. Cancer Res. 2000; 60 (4): 883-7
Dosimetric effects of patient displacement and collimator and gantry angle misalignment on intensity modulated radiation therapy. Xing L, Lin Z, Donaldson SS, Le QT, Tate D, Goffinet DR, Wolden S, Ma L, Boyer AL. Radiother Oncol. 2000; 56 (1): 97-108
Treatment of maxillary sinus carcinoma: a comparison of the 1997 and 1977 American Joint Committee on cancer staging systems. Le QT, Fu KK, Kaplan M, Terris DJ, Fee WE, Goffinet DR. Cancer. 1999; 86 (9): 1700-11
Post-operative irradiation of minor salivary gland malignancies of the head and neck. Le QT, Birdwell S, Terris DJ, Gabalski EC, Varghese A, Fee WE, Goffinet DR.. Radiotherapy Oncology. 1999; 2 (52): 165-71
DNA damage measured by the comet assay in head and neck cancer patients treated with tirapazamine. Dorie MJ, Kovacs MS, Gabalski EC, Adam M, Le QT, Bloch DA, Pinto HA, Terris DJ, Brown JM. Neoplasia. 1999; 1 (5): 461-7
Apoptosis-associated proteins and the development of oral squamous cell carcinoma. Schoelch ML, Le QT, Silverman S, McMillan A, Dekker NP, Fu KK, Ziober BL, Regezi JA. Oral Oncol. 1999; 35 (1): 77-85
Cell cycle proteins and the development of oral squamous cell carcinoma. Schoelch ML, Regezi JA, Dekker NP, Ng IO, McMillan A, Ziober BL, Le QT, Silverman S, Fu KK. Oral Oncol. 1999; 35 (3): 333-42
Optimization of importance factors in inverse planning. Xing L, Li JG, Donaldson S, Le QT, Boyer AL. Phys Med Biol. 1999; 44 (10): 2525-36
Postoperative irradiation of minor salivary gland malignancies of the head and neck. Le QT, Birdwell S, Terris DJ, Gabalski EC, Varghese A, Fee W, Goffinet DR. Radiother Oncol. 1999; 52 (2): 165-71
Estimation theory and model parameter selection for therapeutic treatment plan optimization. Xing L, Li JG, Pugachev A, Le QT, Boyer AL. Med Phys. 1999; 26 (11): 2348-58
A medical knowledge based system for the section of beam orientations in intensity modulated radiation therapy (IMRT). Le QT, Xing L, Pugachev A, Li J , Donaldson S, Goffinet DR, Hancock S, Boyer A.. Int J Radiat Oncol Biol Phys. 1998; 3S (45): 246
Spinal cord dose discrepancy in IMRT treated patients at Stanford revealed by Monte Carlo dose verification: clinical summary. Le QT, Guerrero TM, Pawlicki T, Ma CM, Forster KM, Xing L, Luxton G, Boyer AL, Goffinet DR. ,. Int J Radiat Oncol Biol Phys. 1998; 3S (45): 411
Soft-tissue sarcomas. In: Phillips TL, Leibel S, eds. Le QT, Phillips TL, Leibel S.. Textbook of Radiation Oncology, 1st Edition. Philadelphia: WB Saunders. 1998; 1047-1066.
Adult medulloblastoma: an analysis of survival and prognostic factors. Le QT, Weil MD, Wara WM, Lamborn KR, Prados MD, Edwards MS, Gutin PH. Cancer J Sci Am. 1997 Jul-Aug; 3 (4): 238-45
Influence of fraction size, total dose, and overall time on local control of T1-T2 glottic carcinoma. Le QT, Fu KK, Kroll S, Ryu JK, Quivey JM, Meyler TS, Krieg RM, Phillips TL. Int J Radiat Oncol Biol Phys. 1997; 39 (1): 115-26
Prognostic factors in adult soft-tissue sarcomas of the head and neck. Le QT, Fu KK, Kroll S, Fitts L, Massullo V, Ferrell L, Kaplan MJ, Phillips TL. Int J Radiat Oncol Biol Phys. 1997; 37 (5): 975-84
Pattern of recurrence of medulloblastoma after low-dose craniospinal radiotherapy. Wara WM, Le QT, Sneed PK, Larson DA, Prados MD, Levin VA, Edwards MS, Weil MD. Int J Radiat Oncol Biol Phys. 1994; 30 (3): 551-6